Gaofeng Chen Selected Research

huangqi decoction

8/2016	Synergistic anti-liver fibrosis actions of total astragalus saponins and glycyrrhizic acid via TGF-β1/Smads signaling pathway modulation.
7/2015	Astragaloside prevents BDL-induced liver fibrosis through inhibition of notch signaling activation.
4/2012	Huangqi decoction inhibits apoptosis and fibrosis, but promotes Kupffer cell activation in dimethylnitrosamine-induced rat liver fibrosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Gaofeng Chen Research Topics

Disease

11	Fibrosis (Cirrhosis) 12/2021 - 01/2008
11	Liver Cirrhosis (Hepatic Cirrhosis) 12/2021 - 01/2008
4	Inflammation (Inflammations) 12/2021 - 01/2010
3	Non-alcoholic Fatty Liver Disease 06/2022 - 01/2016
3	Liver Diseases (Liver Disease) 12/2020 - 07/2015
2	Body Weight (Weight, Body) 06/2022 - 01/2016
1	Coronary Disease (Coronary Heart Disease) 02/2022
1	Hyperlipidemias (Hyperlipidemia) 02/2022
1	Atherosclerosis 02/2022
1	Wounds and Injuries (Trauma) 12/2021
1	Intrahepatic Cholestasis 01/2018
1	Cholestasis 01/2018
1	Necrosis 01/2010

Drug/Important Bio-Agent (IBA)

5	Dimethylnitrosamine (Nitrosodimethylamine)IBA 12/2021 - 01/2008
4	CollagenIBA 12/2021 - 01/2010
4	Proteins (Proteins, Gene)FDA Link 12/2020 - 01/2010
3	LipidsIBA 06/2022 - 01/2016
3	Pharmaceutical PreparationsIBA 12/2020 - 07/2015
3	Carbon Tetrachloride (Tetrachloromethane)IBA 12/2020 - 01/2015
3	huangqi decoctionIBA 08/2016 - 04/2012
2	Messenger RNA (mRNA)IBA 12/2021 - 01/2019
2	2-Acetylaminofluorene (2 Acetylaminofluorene)IBA 12/2021 - 01/2015
2	salvianolic acid BIBA 01/2019 - 01/2010
2	Huang QiIBA 07/2015 - 01/2008
2	Therapeutic UsesIBA 04/2012 - 01/2008
1	Glucose (Dextrose)FDA LinkGeneric 06/2022
1	Protons (Proton)IBA 06/2022
1	oxidized low density lipoproteinIBA 02/2022
1	qushi huayuIBA 02/2022
1	LDL CholesterolIBA 02/2022
1	Matrix Metalloproteinases (MMPs)IBA 12/2021
1	GenisteinIBA 12/2021
1	Metalloproteases (Metalloproteinases)IBA 12/2021
1	yiguanjian decoctionIBA 12/2021
1	CytokinesIBA 12/2021
1	Emodin (Archin)IBA 12/2020
1	aloe emodinIBA 12/2020
1	rheinIBA 12/2020
1	prunasinIBA 12/2020
1	ethyl acetateIBA 12/2020
1	schisanhenolIBA 06/2020
1	LignansIBA 06/2020
1	Mitogen-Activated Protein KinasesIBA 06/2020
1	Transforming Growth Factors (Transforming Growth Factor)IBA 06/2020
1	ElementsIBA 01/2019
1	Bile Acids and Salts (Bile Acids)IBA 01/2018
1	Ursodeoxycholic Acid (Urso)FDA LinkGeneric 01/2018
1	1-Naphthylisothiocyanate (1 Naphthylisothiocyanate)IBA 01/2018
1	Alanine Transaminase (SGPT)IBA 08/2016
1	SaponinsIBA 08/2016
1	Glycyrrhizic Acid (Glycyrrhizin)IBA 08/2016
1	Lysine (L-Lysine)FDA Link 01/2016
1	MitogensIBA 01/2016
1	glycyrrhizae radix et rhizomaIBA 07/2015
1	Hematoxylin (Haematoxylon)IBA 02/2015
1	Eosine Yellowish-(YS) (Eosin)IBA 02/2015
1	yinchenhaoIBA 01/2008
1	yiguanIBA 01/2008
1	shosaiko-to (TJ9)IBA 01/2008

Therapy/Procedure

2	Chinese Traditional Medicine (Traditional Chinese Medicine) 06/2022 - 12/2020
2	Ligation 08/2016 - 07/2015
1	Intraperitoneal Injections 12/2021
1	Oral Administration 12/2021
1	Drug Therapy (Chemotherapy) 12/2021
1	Therapeutics 01/2016
1	Protein-Restricted Diet (Diet, Protein Restricted) 01/2016
1	Synchrotrons 02/2015
1	Subcutaneous Injections 01/2015